Literature DB >> 11787082

Mechanistic aspects of HIV-1 reverse transcription initiation.

David Harrich1, Bill Hooker.   

Abstract

During reverse transcription, the positive-strand HIV-1 RNA genome is converted into a double-stranded DNA copy which can be permanently integrated into the host cell genome. Recent analyses show that HIV-1 reverse transcription is a highly regulated process. The initiation reaction can be distinguished from a subsequent elongation reaction carried out by a reverse transcription complex composed of (at least) heterodimeric reverse transcriptase, cellular tRNA(lys3) and HIV-1 genomic RNA sequences. In addition, viral factors including Tat, Nef, Vif, Vpr, IN and NCp7, cellular proteins, and TAR RNA and other RNA stem-loop structures appear to influence this complex and contribute to the efficiency of the initiation reaction. As viral resistance to many antiretroviral compounds is a continuing problem, understanding the ways in which these factors influence the reverse transcription complex will likely lead to novel antiretroviral strategies. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11787082     DOI: 10.1002/rmv.339

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN: 1052-9276            Impact factor:   6.989


  15 in total

Review 1.  Conformational changes in HIV-1 reverse transcriptase induced by nonnucleoside reverse transcriptase inhibitor binding.

Authors:  Nicolas Sluis-Cremer; N Alpay Temiz; Ivet Bahar
Journal:  Curr HIV Res       Date:  2004-10       Impact factor: 1.581

2.  Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.

Authors:  Johanna Wapling; Katie L Moore; Secondo Sonza; Johnson Mak; Gilda Tachedjian
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Few mutations in the 5' leader region mediate fitness recovery of debilitated human immunodeficiency type 1 viruses.

Authors:  Eloísa Yuste; Antonio V Bordería; Esteban Domingo; Cecilio López-Galíndez
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  Probing the importance of tRNA anticodon: human immunodeficiency virus type 1 (HIV-1) RNA genome complementarity with an HIV-1 that selects tRNA(Glu) for replication.

Authors:  Lesley C Dupuy; Nathan J Kelly; Tricia E Elgavish; Stephen C Harvey; Casey D Morrow
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 protease regulation of tat activity is essential for efficient reverse transcription and replication.

Authors:  Ann Apolloni; C William Hooker; Johnson Mak; David Harrich
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Molecular docking of (5E)-3-(2-aminoethyl)-5-(2- thienylmethylene)-1, 3-thiazolidine-2, 4-dione on HIV-1 reverse transcriptase: novel drug acting on enzyme.

Authors:  Chandrabhan Seniya; Ajay Yadav; Kuldeep Uchadia; Sanjay Kumar; Nitin Sagar; Priyanka Shrivastava; Shilpi Shrivastava; Gulshan Wadhwa
Journal:  Bioinformation       Date:  2012-07-21

7.  Initiation complex dynamics direct the transitions between distinct phases of early HIV reverse transcription.

Authors:  Shixin Liu; Bryan T Harada; Jennifer T Miller; Stuart F J Le Grice; Xiaowei Zhuang
Journal:  Nat Struct Mol Biol       Date:  2010-11-21       Impact factor: 15.369

8.  The availability of the primer activation signal (PAS) affects the efficiency of HIV-1 reverse transcription initiation.

Authors:  Marcel Ooms; Daniel Cupac; Truus E M Abbink; Hendrik Huthoff; Ben Berkhout
Journal:  Nucleic Acids Res       Date:  2007-02-18       Impact factor: 16.971

9.  Human immunodeficiency virus type-1 reverse transcriptase exists as post-translationally modified forms in virions and cells.

Authors:  Adam J Davis; Jillian M Carr; Christopher J Bagley; Jason Powell; David Warrilow; David Harrich; Christopher J Burrell; Peng Li
Journal:  Retrovirology       Date:  2008-12-18       Impact factor: 4.602

10.  Functional relevance of nonsynonymous mutations in the HIV-1 tat gene within an epidemiologically-linked transmission cohort.

Authors:  Haran Sivakumaran; Bin Wang; M John Gill; Brenda Beckholdt; Nitin K Saksena; David Harrich
Journal:  Virol J       Date:  2007-10-25       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.